Medtronic Gains FDA Approval for Hugo Robotic Surgical System
In December 2025, Medtronic received U.S. Food and Drug Administration (FDA) approval to use its Hugo robotic-assisted surgery platform in urologic procedures such as prostatectomy, nephrectomy, and cystectomy. This marks a significant step for the company entering a market dominated by Intuitive Surgical's da Vinci system.
Topics: market competition medical technology robotic surgery